{"id":"W3164862257","doi":"10.1016/j.xfre.2021.05.004","title":"Efficacy and safety of elagolix with add-back therapy in women with uterine fibroids and coexisting adenomyosis","year":2021,"lang":"en","type":"article","venue":"F&S Reports","topic":"Endometriosis Research and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Agency for Healthcare Research and Quality; AbbVie","keywords":"Adenomyosis; Medicine; Clinical endpoint; Placebo; Uterine fibroids; Adverse effect; Gynecology; Confidence interval; Internal medicine; Randomized controlled trial; Obstetrics; Urology; Uterus; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004557098,0.0008096382,0.00326167,0.000798969,0.0002696917,0.0009319835,0.000672656,0.001499109,0.002496974],"category_scores_gemma":[0.007817878,0.0006129187,0.003572808,0.0005748884,0.0007647452,0.0007113364,0.0004465335,0.001363609,0.0002031442],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007430012,"about_ca_system_score_gemma":0.0008923911,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00102359,"about_ca_topic_score_gemma":0.002375041,"domain_scores_codex":[0.9973536,0.001620499,0.0003454099,0.0002472177,0.0003142014,0.0001190706],"domain_scores_gemma":[0.9966794,0.001685043,0.001102274,0.0001205173,0.0001710714,0.0002416706],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9080465,0.002107762,0.004613817,0.006467689,0.01495454,0.00008442164,0.00009230525,0.0005348009,0.003871083,0.00007201016,0.000314548,0.05884069],"study_design_scores_gemma":[0.8233112,0.1347899,0.02057681,0.0007808959,0.01670733,0.0002313189,0.00008589326,0.0005610594,0.00140738,0.000129221,0.001385962,0.0000329997],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8766473,0.1170281,0.0007763953,0.000649976,0.0003208694,0.001941143,0.000604159,0.00006661272,0.001965486],"genre_scores_gemma":[0.9804564,0.01580541,0.001118167,0.0005152718,0.0003691032,0.0009094255,0.0003835816,0.000007812015,0.0004347685],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004557098,"threshold_uncertainty_score":0.02410054,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01944268618455314,"score_gpt":0.3009481062799821,"score_spread":0.281505420095429,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}